Medicinal – Page 117

Engineered biosynthesis and characterization of disaccharide-pimaricin

mycolabadmin

Scientists engineered a bacterium to produce a modified antibiotic called disaccharide-pimaricin that fights fungal infections with much better safety. This new compound dissolves better in water (107 times more soluble) and is much less toxic to human blood cells (12.6 times safer) compared to regular pimaricin, while still maintaining antifungal effectiveness. Through optimized fermentation processes, they achieved high production yields of 138 mg/L, making this a promising candidate for safer antifungal treatments.

Fungal vaccines: so needed, so feasible, and yet so far off

mycolabadmin

Fungal infections kill millions of people worldwide each year, particularly those with weakened immune systems, yet no vaccines exist to prevent them. Scientists have discovered that a specific fungal enzyme called Eng2 can trigger protective immune responses against three major disease-causing fungi. A vaccine containing this enzyme from all three fungi species could potentially protect against multiple dangerous fungal infections, though challenges like cost and the need to work in immunocompromised patients remain before such vaccines reach patients.

First Step on the Way to Identify Dermatophytes Using Odour Fingerprints

mycolabadmin

Researchers have developed a new method to quickly identify fungal skin infections caused by dermatophytes by detecting the unique smells (volatile compounds) they produce. Instead of waiting days or weeks for culture-based tests, this approach uses advanced chemical analysis to create a fingerprint of the fungus based on its odor. The study analyzed 47 different dermatophyte strains and found that each species and even individual strains have distinctive chemical signatures, which could one day allow doctors to diagnose infections rapidly using portable devices similar to electronic noses.

De novo genome sequencing and comparative analyses of the clinically relevant species Mucor ardhlaengiktus, Mucor circinelloides, Mucor griseocyanus, and Mucor janssenii

mycolabadmin

Scientists have sequenced and analyzed the complete genomes of four species of Mucor fungus that cause serious infections in humans. Using advanced long-read sequencing technology, they created high-quality genetic blueprints for these organisms, which will help doctors better identify which Mucor species is causing infections and enable faster diagnosis and treatment of these dangerous fungal infections.

Potential of Indonesian Herbal as an Anti-Cancer Therapy: A Systemic Review of in vitro Studies

mycolabadmin

This review examined eight Indonesian herbal plants that show promise in laboratory studies for fighting various types of cancer. Soursop leaves were the most researched and consistently showed the ability to kill or slow cancer cells in test tubes by triggering natural cell death pathways. The herbs work through bioactive compounds like flavonoids and alkaloids that can interfere with how cancer cells divide and survive. While these results are encouraging, more research is needed to confirm effectiveness in humans.

Characterization of the Spatiotemporal Localization of a Pan-Mucorales–Specific Antigen During Germination and Immunohistochemistry

mycolabadmin

Researchers developed a new diagnostic test using a special antibody that can detect Mucorales fungi, which cause a serious infection called mucormycosis. The antibody glows to mark growing fungal threads in tissue samples, helping doctors identify the infection early and distinguish it from other mold infections like Aspergillus. This breakthrough could significantly improve patient outcomes by enabling faster diagnosis and treatment of this aggressive fungal disease.

Global, Regional, and National Burden of Pulmonary Fungal Infections 1990–2021

mycolabadmin

This study analyzed the global impact of fungal lung infections from 1990 to 2021, finding that about 5.6 million people were affected in 2021 with significant mortality rates. The burden of these infections is particularly high in low- and middle-income countries and affects older individuals more severely. The researchers project that deaths from fungal lung infections will double by 2044, emphasizing the need for better prevention strategies, vaccines, and international cooperation to address this growing health challenge.

Deciphering the role of CAPZA2 in neurodevelopmental disorders: insights from mouse models

mycolabadmin

Scientists studied a gene called CAPZA2 that helps control how brain cells connect to each other. When this gene doesn’t work properly, mice had trouble learning, remembering things, and interacting socially, similar to intellectual disability in humans. The researchers found that the problem happens because the connections between brain cells become abnormal and don’t mature properly. This research helps explain why some people with mutations in this gene have developmental difficulties and could lead to new treatments.

Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy

mycolabadmin

Two patients developed rare fungal eye infections caused by Curvularia geniculata after eye injuries from plant material. The infections caused corneal ulcers with characteristic feathery infiltrates. Both patients were successfully treated using natamycin eyedrops, either alone or combined with voriconazole, and both recovered excellent vision. Accurate identification of the fungus using genetic testing confirmed the diagnosis and helped guide treatment decisions.

Prevalence of Compartment Syndrome and Disseminated Intravascular Coagulation following Rhabdomyolysis; a Systematic Review and Meta-Analysis

mycolabadmin

This study analyzed twenty research papers to understand how often two serious complications occur in patients with rhabdomyolysis, a condition involving muscle damage. Compartment syndrome, where pressure builds up around muscles limiting blood flow, occurred in about 4% of cases overall but was slightly more common in severe cases. Disseminated intravascular coagulation, a dangerous blood clotting disorder, occurred in about 8% of patients. These findings help doctors better understand and monitor for these potentially life-threatening complications.

Research Topic: Medicinal